参考文献/References:
[1] Sandercock P,Wardlaw JM,Lindley RI,et al.The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke(the third international stroke trial: a randomised controlled trial[J].Lancet,2012,379(9834):2352-2363.
[2] Whiteley WN,Slot KB,Fernandes P,et al.Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies[J].Stroke,2012,43(11):2904-2909.
[3] Carmeliet P,Schoonjans L,Kieckens L,et al.Van den Oord JJ; collen D; mulligan RC.physiological Consequences of loss of plasminogen activator gene function in mice[J].Nature International Weekly Journal of Science,1994,368(6470):419-424.
[4] 朱大年主编·生理学[M].北京:人民卫生出版社,2007.
[5] Oliver J,Webb J,Newby E.Stimulated tissue plasminogen activator release as a marker of endothelial function in humans[J].Arterioscler Thromb Vasc Biol,2005,25(12):2470-2479.
[6] Sappino P,Madani R,Huarte J,et al.Extracellular proteolysis in the adult murine brain[J].J Clin Invest,1993,92(2):679-685.
[7] Colucci Mario,Semeraro Nicola.Thrombin activatable fibrinolysis inhibitor: at the nexus of fibrinolysis and inflammation[J].Thromb Res,2012,129(3):314-319.
[8] Damare J,Brandal S.Fortenberry YM.Inhibition of DAI-I antiprotevlytic activity against t PA by RNA aptanmers[J].Nucleic Acid Therapeutics,2014,24(4):239.
[9] Chandler L,Trimble L,Loo C,et al.Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator(t-PA)and t-PA/PAI-1 complex in plasma[J].Blood,1990,76(5):930-937.
[10] Jin Rong,Yang Guojun,Li Guohong.Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator[J].Neurobiol Dis,2010,38(3):376-385.
[11] Ladenvall Claes,Gils Ann,Jood Katarina,et al.Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation[J].Arterioscler Thromb Vasc Biol,2007,27(4):955-962.
[12] Mehta H,Cox Margueritte,Smith E,et al.Race/ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy[J].Stroke,2014,45(8):2263-2269.
[13] Gonz lez-Conejero Rocio,Fern ndez-Cadenas Israel,Iniesta A,et al.Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients[J].Stroke,2006,37(9):2288-2293.
[14] Sun Xunsha,Lai Rong,Li Jiaoxing,et al.The-7351C/T polymorphism in the TPA gene and ischemic stroke risk: a meta-analysis[J].PLoS One,2013,8(1):e53558.
[15] Babu Sai,Prabha Surya,Kaul Subhash,et al.Association of genetic variants of fibrinolytic system with stroke and stroke subtypes[J].Gene,2012,495(1):76-80.
[16] Naess Halvor,Idicula T,Lagallo N,et al.Inverse relationship of baseline body temperature and outcome between ischemic stroke patients treated and not treated with thrombolysis: the Bergen stroke study[J].Acta Neurol Scand,2010,122(6):414-417.
[17] Leira Rogelio,Sobrino Tom s,Blanco Miguel,et al.A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator(rtPA)[J].Clin Sci(Lond),2012,122(3):113-119.
[18] Shon Hyun,Heo Hyuk,Kim Joon,et al.Predictors of hemorrhage volume after intravenous thrombolysis[J].J Stroke Cerebrovasc Dis,2016,25(10):2543-2548.
[19] Mateen J,Buchan M,Hill D,et al.Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians[J].Stroke,2010,41(8):1833-1835.
[20] Sylaja N,Cote Robert,Buchan M,et al.Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study[J].J Neurol Neurosurg Psychiatry,2006,77(7):826-829.
[21] Tanne David,Kasner E,Demchuk M,et al.Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey[J].Circulation,2002,105(14):1679-1685.
[22] K hrmann Martin,J ttler Eric,Fiebach B,et al.MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study[J].The Lancet Neurology,2006,5(8):661-667.
[23] Derex L,Hermier M,Adeleine P,et al.Derex,L.et al.clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator.J.neurol.neurosurg.psychiatry 76,70-75[J].Journal of Neurology Neurosurgery&Psychiatry,2005,76(1):70-75.
[24] Paciaroni Maurizio,Agnelli Giancarlo,Caso Valeria,et al.Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke[J].Cerebrovasc Dis,2009,28(2):119-123.